SD Biotechnologies delays shareholder vote, shifts reverse stock split timeline to Dec. 3 listing
Bitget2026/09/23 04:49- SD Biotechnologies revised its reverse stock split timetable due to a delay in holding an extraordinary shareholders’ meeting.
- The meeting date was moved to Oct. 15, 2026 from Oct. 8, 2026.
- New shares will take effect Nov. 17, 2026; trading will be halted Nov. 13–Dec. 2, 2026; relisting is set for Dec. 3, 2026.
- The reverse split keeps par value at KRW 1,000 from KRW 200; common shares outstanding will drop to 21,946,628 from 109,733,141.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
India Relaxes Asset Management Rules: Portfolio Management Industry Approved for Overseas Investment and Short Selling Stocks for the First Time
Indian regulators announced on Thursday that they will allow the country’s $463 billion portfolio management industry to invest in overseas securities for the first time and to conduct short-selling in stock options. This move opens up new channels for India’s wealthy class to access global markets and holds significance for AI-related assets, which have attracted strong investor interest. Additionally, India will launch new portfolio management products with lower investment thresholds.

Waldencast Files to Delist Shares, Warrants From Nasdaq

Verdera Energy Completes Sale of Treeline Uranium Project in New Mexico
Banzai revises private placement terms, sets $250,000 cross-default threshold